
Enrique Grande
@drenriquegrande
Jefe del Servicio de Oncología Médica en MD Anderson Cancer Center Madrid. Opinions are my own. coi.asco.org/share/JQ8-HCZ7…
ID: 386490186
https://mdanderson.es/ 07-10-2011 11:27:25
13,13K Tweet
11,11K Followers
7,7K Following


⚡️ New preclinical data reveal key differences in treatment response for renal medullary carcinoma (RMC) vs FH-deficient RCC. ✔️ Erlotinib effective in both ✔️ Bevacizumab only in FH-deficient RCC RMC appears resistant to anti-VEGF therapy #KidneyCancer Pavlos Msaouel




Tracking and tackling an increasing trend in young-onset bladder/urothelial cancer. Presentation by Mario Fernández, MD, Melanie Pepin, MS, CGC, and Kristen Watts. #BCANTT25 written coverage by Julian Chavarriaga University of Toronto > bit.ly/4ohfzm9 Bladder Cancer Advocacy Network Ashish M. Kamat, MD, MBBS Shilpa Gupta.




Our SEER-based study shows that pts with cN+ M0 bladder cancer who received chemotherapy + radical cystectomy had better CSS and OS compared to those who had chemoradiation. The 5-yr OS was only 25%. sciencedirect.com/science/articl… Pietro Scilipoti Marco Moschini Benjamin Pradere Stephen Boorjian, MD


🚨 NEW STUDY | Inside Cancer Cancer Research Communications AACR 🌟🔬Prostate-Specific Antigen Secretion from Single Circulating Tumor Cells in mCNPC🌟 👨🔬 Authors: Eshwari Dathathri & Leon W.M.M. Terstappen OncoAlert Advanced Prostate Cancer Consensus Conference 📊 Key Findings: 🧬 PSA secretion detected in only 9/18 mCNPC pts 📉 Most


⚡️ New study finds no significant link between metabolic syndrome or chronic kidney disease and recurrence or progression of non–muscle invasive bladder cancer (NMIBC). Hypertension, however, was associated with faster progression. #BladderCancer #KidneyDisease Urologic Oncology



10 Must-Read Posts in Immuno-Oncology This Week oncodaily.com/societies/10-i… Yakup Ergün Yan Leyfman, MD MSD Elsa Anagnostou Enrique Grande UAB Neurosurgery Jenny Seligmann Arndt Vogel Dr. Estela Rodriguez #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews





⚡️ Journal of Clinical Oncology - The management of Muscle Invasive Bladder Cancer is entering a new era. Integration of immune checkpoint inhibitors, ctDNA for MRD detection, and ADC combinations promise risk-adapted strategies & better outcomes. A true watershed moment. #BladderCancer





IUCS25 Clinical Case Poll 69 y/o man, PS0, de novo metastatic bladder TCC, node-only, CrCl 80, PD-L1 20% What’s your 1st-line choice?👇 Vote & join the conversation 🗳️ Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Yüksel Ürün Enrique Grande Petros Grivas Elena Castro Giuseppe Banna Ravindran Kanesvaran